Genomic biomarkers, such as PNPLA3 and TM6SF2, are increasingly used to enrich clinical study populations for genotypes associated with certain disease phenotypes.
Genomic biomarkers, such as PNPLA3 and TM6SF2, are increasingly used to enrich clinical study populations for genotypes associated with certain disease phenotypes.
